Issue 7 July 2023

Trusts moving to using licensed Xaqua® (metolazone) 5mg tablets; Avoid Selecting a DPI / Breath-Actuated Inhaler when A Spacer Device is Required; Changes to Red Amber List Medicines; Did you see? — Changes to NI Formulary for Chronic Pain; NICE Guidance (Recently Published); Managed entry Decisions